Latest Breaking News On - Sartorius stedim biotech group - Page 14 : comparemela.com

Sartorius Stedim Biotech looks back on a very successful 2020 and. Sartorius Stedim Biotech looks back on a very successful 2020 and expects further strong growth Aubagne, February 18, 2021 Outlook for the current year: sales projected to increase by 20 percent to 26 percent Accelerated and greater ramp-up of production capacities in all geographies; CAPEX ratio of 15 percent expected for 2021 Group management raises sales target for 2025 to about 4 billion euros Sartorius Stedim Biotech, a leading partner of the biopharma industry, confirmed its preliminary figures for 2020 upon the release of its Universal Registration Document 2020 including the Annual Financial Report. Group sales revenue surged by 34.6 percent to 1,910 million euros in constant currencies (reported: +32.6 percent). Order intake

Puerto ricoSouth koreaJoachim kreuzburgSartorius stedim biotech groupSartorius stedim biotechUniversal registration documentAnnual financialAnnual shareholder meetingStedim biotechMiddle eastSartorius ag via public stedim biotech looks back ona very successful 2020 andப்வெர்டோ ரிக்கோதெற்கு கொரியாஉலகளாவிய பதிவு ஆவணம்ஆண்டு நிதிஆண்டு பங்குதாரர் சந்தித்தல்